Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	315.35	386.19	200.84	86.47	183.88
Cash & Short-Term Investments	315.35	386.19	200.84	86.47	183.88
Cash Growth	-18.34%	92.29%	132.26%	-52.97%	-16.41%
Receivables	142	94.82	37.7	-	-
Inventory	15.73	15.14	4.32	-	-
Prepaid Expenses	11.98	8.12	2.78	0.05	0.15
Total Current Assets	485.06	504.26	245.64	86.52	184.02
Property, Plant & Equipment	5.97	7.62	1.14	0.94	1.79
Goodwill	12.04	12.04	10.31	-	-
Other Intangible Assets	46.89	53.29	59.66	-	-
Other Long-Term Assets	18.53	11.03	14.72	0.32	0.32
Total Assets	568.5	588.24	331.48	87.79	186.13
Accounts Payable	72	40.68	38.61	13.15	13.5
Accrued Expenses	145.61	90.5	51.63	9.3	8.71
Current Portion of Leases	3.26	1.27	0.43	0.62	1.22
Current Income Taxes Payable	0.96	-	-	-	-
Other Current Liabilities	8.29	6.41	5.9	-	-
Total Current Liabilities	230.1	138.85	96.56	23.07	23.44
Long-Term Debt	180.71	178.07	94.26	49.09	48.32
Long-Term Leases	8.99	7.04	-	-	0.58
Other Long-Term Liabilities	91.68	73.3	31.1	-	-
Total Liabilities	511.48	397.26	221.92	72.15	72.34
Common Stock	0.01	0.01	0	0	0
Additional Paid-In Capital	1,180	1,027	705.89	424.83	392.59
Retained Earnings	-1,123	-835.57	-596.33	-409.2	-278.8
Shareholders' Equity	57.02	190.98	109.56	15.63	113.79
Total Liabilities & Equity	568.5	588.24	331.48	87.79	186.13
Total Debt	192.96	186.37	94.68	49.71	50.12
Net Cash (Debt)	122.4	199.82	106.16	36.76	133.75
Net Cash Growth	-38.75%	88.23%	188.77%	-72.51%	-33.13%
Net Cash Per Share	2.55	4.40	2.61	0.98	3.59
Filing Date Shares Outstanding	48.77	47.37	43.52	38.48	37.41
Total Common Shares Outstanding	48.67	47.35	43.5	37.82	37.37
Working Capital	254.96	365.41	149.08	63.45	160.59
Book Value Per Share	1.17	4.03	2.52	0.41	3.04
Tangible Book Value	-1.92	125.65	39.59	15.63	113.79
Tangible Book Value Per Share	-0.04	2.65	0.91	0.41	3.04

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q